...campaign to prevent genetically modified salmon from reaching American grocery store shelves. Recovering from an Epic... ...Hahn accomplished his principal mission, leading the institution’s recovery from a disastrous transition to the Epic...
...resulted in “increases of efficiency, data quality and timeliness.” REDCap is connecting directly to local EPIC... ...record systems to allow data flow to proceed in real-time. Twenty-four academic institutions that use EPIC...
...Ltd. (Cambridge, U.K.) and Foster was portfolio manager at Meltwind Advisory LLP. Cancer diagnostic company Epic... ...Wong, Staff Writer, and Steve Usdin, Washington Editor
Akrevia Therapeutics LLC
Cell Mogrify Ltd.
Celsius Therapeutics
DNAnexus Inc.
Eiger BioPharmaceuticals Inc.
Epic...
...DeWildt to chief commercial officer from SVP of commercial and market access. Cancer diagnostic company Epic... ...Transmembrane protein 173; TNFSF13 (APRIL) - Tumor necrosis factor ligand superfamily member 13
BioCentury Staff
Aduro Biotech
Epic...
...Lloyd Sanders will succeed Murali Prahalad as president and CEO of cancer diagnostic company Epic Sciences... ...Myriad Genetics Inc. (NASDAQ:MYGN). Prahalad, who has stepped down to pursue other opportunities, will join Epic’s... ...N.J.). He succeeds interim CEO Shenda Baker, who remains CSO and a director.
BioCentury Staff
Axcella Health Inc.
Epic...
...campaign to prevent genetically modified salmon from reaching American grocery store shelves. Recovering from an Epic... ...Hahn accomplished his principal mission, leading the institution’s recovery from a disastrous transition to the Epic...
...resulted in “increases of efficiency, data quality and timeliness.” REDCap is connecting directly to local EPIC... ...record systems to allow data flow to proceed in real-time. Twenty-four academic institutions that use EPIC...
...Ltd. (Cambridge, U.K.) and Foster was portfolio manager at Meltwind Advisory LLP. Cancer diagnostic company Epic... ...Wong, Staff Writer, and Steve Usdin, Washington Editor
Akrevia Therapeutics LLC
Cell Mogrify Ltd.
Celsius Therapeutics
DNAnexus Inc.
Eiger BioPharmaceuticals Inc.
Epic...
...DeWildt to chief commercial officer from SVP of commercial and market access. Cancer diagnostic company Epic... ...Transmembrane protein 173; TNFSF13 (APRIL) - Tumor necrosis factor ligand superfamily member 13
BioCentury Staff
Aduro Biotech
Epic...
...Lloyd Sanders will succeed Murali Prahalad as president and CEO of cancer diagnostic company Epic Sciences... ...Myriad Genetics Inc. (NASDAQ:MYGN). Prahalad, who has stepped down to pursue other opportunities, will join Epic’s... ...N.J.). He succeeds interim CEO Shenda Baker, who remains CSO and a director.
BioCentury Staff
Axcella Health Inc.
Epic...